The recent Unitaid report highlights a complex issue in climate change: the significant environmental impact of essential public health items crucial for saving lives. These items, such as mosquito nets, pills, and rapid tests, contribute about 3.5 megatons of greenhouse gases annually, surpassing Geneva’s total emissions. The report suggests that reducing these emissions by 70% by 2030 is possible through strategies that don’t require additional costs.
Critical contributors to emissions include energy-intensive production of pharmaceuticals, like the HIV drug dolutegravir, and products with high plastic content, like malaria nets and PCR tests. The report indicates that renewable energy use, supply chain optimization, and new materials can substantially lower emissions. Some solutions might be expensive initially but are financially beneficial in the long run.
Unitaid emphasizes the role of manufacturers and health agencies in adopting greener practices. For instance, prioritizing contracts for environmentally conscious manufacturers can encourage innovation in public health products. The report also notes the importance of choosing environmentally friendly solutions, such as preferring vaccines that don’t require refrigeration when equally effective options are available.
Furthermore, the production methods of health products can create a cycle where their effectiveness is reduced, as seen in cases like antibiotic waste leading to resistance. The report is a pivotal tool for policymakers, urging them to revise policies to encourage sustainable production practices. This perspective is supported by experts like Cheryl Damberg of RAND, who sees the report as a potential catalyst for different policy discussions focused on environmental sustainability in health product manufacturing.
To read more, click here.
[Source: STAT, November 30th, 2023]